Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer

Abstract

Our data shows that PIK3CA mutations and PI3K/AKT pathway activation are common events in TNBC. A deeper investigation on specific TNBC genomic abnormalities might be helpful in order to select patients who would benefit from current targeted therapy strategies.